<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xu W</submitter><funding>Medical Research Council</funding><pagination>e15279</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11451341</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>41(6)</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>Evidence is accumulating of the therapeutic benefits of mesenchymal stromal cells (MSCs) in diabetes-related conditions. We have identified a novel population of stromal cells within islets of Langerhans - islet stellate cells (ISCs) - which have a similar morphology to MSCs. In this study we characterize mouse ISCs and compare their morphology and function to MSCs to determine whether ISCs may also have therapeutic potential in diabetes.&lt;h4>Methods&lt;/h4>ISCs isolated from mouse islets were compared to mouse bone marrow MSCs by analysis of cell morphology; expression of cell-surface markers and extracellular matrix (ECM) components; proliferation; apoptosis; paracrine activity; and differentiation into adipocytes, chondrocytes and osteocytes. We also assessed the effects of co-</pubmed_abstract><journal>Diabetic medicine : a journal of the British Diabetic Association</journal><pubmed_title>Mouse islet-derived stellate cells are similar to, but distinct from, mesenchymal stromal cells and influence the beta cell function.</pubmed_title><pmcid>PMC11451341</pmcid><funding_grant_id>MR/W002876/1</funding_grant_id><pubmed_authors>King AJF</pubmed_authors><pubmed_authors>Jones PM</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Hong TW</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Sun Z</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Liang J</pubmed_authors><pubmed_authors>Persaud SJ</pubmed_authors><pubmed_authors>Liu B</pubmed_authors><pubmed_authors>Ni C</pubmed_authors><pubmed_authors>Xu W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mouse islet-derived stellate cells are similar to, but distinct from, mesenchymal stromal cells and influence the beta cell function.</name><description>&lt;h4>Aims&lt;/h4>Evidence is accumulating of the therapeutic benefits of mesenchymal stromal cells (MSCs) in diabetes-related conditions. We have identified a novel population of stromal cells within islets of Langerhans - islet stellate cells (ISCs) - which have a similar morphology to MSCs. In this study we characterize mouse ISCs and compare their morphology and function to MSCs to determine whether ISCs may also have therapeutic potential in diabetes.&lt;h4>Methods&lt;/h4>ISCs isolated from mouse islets were compared to mouse bone marrow MSCs by analysis of cell morphology; expression of cell-surface markers and extracellular matrix (ECM) components; proliferation; apoptosis; paracrine activity; and differentiation into adipocytes, chondrocytes and osteocytes. We also assessed the effects of co-</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2025-04-18T14:35:33.298Z</modification><creation>2025-04-07T00:48:10.71Z</creation></dates><accession>S-EPMC11451341</accession><cross_references><pubmed>38185936</pubmed><doi>10.1111/dme.15279</doi></cross_references></HashMap>